QDVG:F:F-iShares S&P 500 Health Care Sector UCITS ETF (EUR)

ETF | Others |

Last Closing

USD 11.022

Change

-0.03 (-0.29)%

Market Cap

N/A

Volume

350.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-21 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
PRAJ:F Amundi Index Solutions - Amund..

-0.30 (-1.12%)

USD 139.20B
UIM5:F UBS (Lux) Fund Solutions - MSC..

-0.55 (-1.07%)

USD 114.12B
SXR8:F iShares Core S&P 500 UCITS ETF..

+0.94 (+0.16%)

USD 99.24B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

N/A

USD 94.03B
SXRZ:F iShares VII PLC - iShares Nikk..

-1.85 (-0.77%)

USD 59.61B
XDNY:F Xtrackers MSCI Japan ESG Scree..

-0.16 (-1.06%)

USD 54.27B
VUAA:F Vanguard S&P 500 UCITS Acc

+0.13 (+0.13%)

USD 51.63B
VUSA:F Vanguard Funds Public Limited ..

+0.10 (+0.09%)

USD 51.63B
XJSE:F Xtrackers II - Japan Governmen..

-0.03 (-0.35%)

USD 40.33B
0ZC:F Zscaler Inc

+0.56 (+0.32%)

USD 37.92B

ETFs Containing QDVG:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 14.97% 66% D+ 66% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 14.97% 67% D+ 66% D+
Trailing 12 Months  
Capital Gain 16.88% 48% F 57% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 16.88% 48% F 57% F
Trailing 5 Years  
Capital Gain 81.49% 88% B+ 79% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 81.49% 88% B+ 79% B-
Average Annual (5 Year Horizon)  
Capital Gain 12.21% 80% B- 73% C
Dividend Return 12.21% 78% C+ 66% D+
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 11.07% 60% D- 86% B+
Risk Adjusted Return 110.26% 99% N/A 97% N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike